Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Biography

With a background in molecular biology and medicine, Prof Henrik Zetterberg has spent the past 15 years focusing on the development of biomarkers for Alzheimer’s disease and other brain disorders - becoming a world expert in the process. He has published more than 1100 scientific articles and has received numerous awards.

News

Key publications

EBioMedicine
Published

Detecting amyloid-β pathology in subjective cognitive decline using plasma and CSF biomarkers

Authors
José Contador, Federico Emanuele Pozzi, Gonzalo Sánchez-Benavides, Ana Fernández-Arcos, Juan Lantero-Rodríguez, Laia Montoliu-Gaya, Carolina Minguillon, Karine Fauria, Armand González-Escalante, Paula Ortiz-Romero, Helena Blasco-Forniés, Marina de Diego-Osaba, Esther Jiménez Moyano, Clara Quijano-Rubio, Gwendlyn Kollmorgen, Nathalie Le Bastard, Alicia Nadal, Eugeen Vanmechelen, Andreas Jeromin, Javier Torres-Torronteras, Nicholas J Ashton, Henrik Zetterberg, Kaj Blennow, Juan Domingo Gispert, José Luis Molinuevo, Marta Del Campo, Oriol Grau-Rivera, Marc Suárez-Calvet, β-AARC Study collaborators
Detecting amyloid-β pathology in subjective cognitive decline using plasma and CSF biomarkers
Alzheimer's research & therapy
Published

Cognitive, biomarker, and neuroimaging indices associated with traumatic encephalopathy syndrome across two independent athlete cohorts

Authors
Brooke D Conway Kleven, Lung-Chang Chien, Dana Surwill, Michael L Alosco, Jennifer V Wethe, Yorghos Tripodis, Charles H Adler, Martha E Shenton, Ofer Pasternak, Douglas I Katz, Elaine Peskind, Laura J Balcer, Inga K Koerte, Jesse Mez, Eric M Reiman, Robert C Cantu, Robert A Stern, Henrik Zetterberg, Charles Bernick, Jeffrey L Cummings
Cognitive, biomarker, and neuroimaging indices associated with traumatic encephalopathy syndrome across two independent athlete cohorts
Alzheimer's & dementia : the journal of the Alzheimer's Association
Published

Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort

Authors
Rosalie J Cottez, Clémence Peyrot, Hélèna L Denis, Cyntia Tremblay, Andréanne Loiselle, Caroline Dallaire-Théroux, Ali Filali-Mouhim, Sébastien S Hébert, Nicole Leclerc, Kaj Blennow, Henrik Zetterberg, Consortium for the Early Identification of Alzheimer's Disease – Quebec (CIMA‐Q), Marie-Jeanne Kergoat, Frédéric Calon, Alexa Pichet Binette
Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort

Zetterberg Lab

Explore the work of the Zetterberg Lab, pioneering the development of fluid biomarkers for dementia

Zetterberg Lab